TFDP2 — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
SCHEMBL3036566	1.00	1/20
SCHEMBL13437301	0.96	1/20
SCHEMBL3481470	0.89	1/20
SCHEMBL3481025	0.89	1/20
SCHEMBL3481331	0.89	1/20
SCHEMBL3481698	0.89	1/20
SCHEMBL3481329	0.88	1/20
SCHEMBL3481210	0.87	1/20
SCHEMBL3481232	0.87	1/20
SCHEMBL13402595	0.87	1/20
SCHEMBL13437415	0.87	1/20
SCHEMBL3481147	0.86	1/20
SCHEMBL3481039	0.86	1/20
SCHEMBL3482294	0.86	1/20
SCHEMBL13402689	0.86	1/20
SCHEMBL13403023	0.85	1/20
SCHEMBL13437344	0.85	1/20
SCHEMBL3481241	0.85	1/20
SCHEMBL3481379	0.85	1/20
SCHEMBL3481141	0.84	1/20

Clinical trials — most relevant to TFDP2 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment	PHASE4	RECRUITING
Prolonged Release Pirfenidone Versus Placebo in Compensated Cirrhosis.	PHASE2	COMPLETED
Treatment With Azacitidine of Recurrent Gliomas With IDH1/2 Mutation	PHASE2	UNKNOWN
Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer	PHASE2	COMPLETED
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS	PHASE2	COMPLETED
Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and AMD3100	PHASE1/PHASE2	COMPLETED
Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies	PHASE1	COMPLETED
SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors	PHASE1	RECRUITING
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck	PHASE1	COMPLETED
Autophagy in Systemic Lupus Erythematosus	nan	UNKNOWN
Gene Expression Variation and Implant Wound Healing Among Smokers and Diabetics	nan	COMPLETED
Evaluation of the Predictive Effect of Inflammatory Markers in MI Patients	nan	UNKNOWN
EPIgenetics and in Vivo Resistance of Chronic Myeloid Leukemia Stem Cells to Tyrosine Kinase Inhibitors	nan	UNKNOWN
Family Resilience Initiative Research Program	nan	UNKNOWN
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors	nan	COMPLETED
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia	nan	UNKNOWN
Zinc and the Synthesis of Zinc Binding Proteins (Protocol B)	nan	COMPLETED
Tecfidera Diffusion Tensor Imaging	nan	COMPLETED
Regulation of Vitamin D Receptor (VDR),Calcium Sensing Receptor (CaSR), Cyclin D1,Ki67 and Proliferating Cell Nuclear Antigen (PCNA) in Primary Hyperparathyroidism	nan	UNKNOWN
The Role of Timing of Dexamethasone Administration on Pain Scores and Quality of Recovery in Cesarean Section.	nan	COMPLETED
Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins.	nan	UNKNOWN
Genetics of Recurrent Early Onset Major Depression	nan	COMPLETED
Study of the Effects of Iron Levels on the Lungs at High Altitude	nan	COMPLETED
Family Blood Pressure Program - GenNet Network	nan	COMPLETED
Spironolactone and XPB-1 Integrity in the TFIIH Complex	nan	ENROLLING_BY_INVITATION
PCD New Gene Discovery	nan	COMPLETED
Study of Proteins in Head and Neck Cancer Cells	nan	COMPLETED
Immunolocalization of 1,25,Dihydroxyvitamin D3 in Aggressive Periodontitis Patients	nan	COMPLETED
Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus	nan	ACTIVE_NOT_RECRUITING
Gene Expression, Metabolomic, Microbiome, and Calcium Metabolism in Response to Varied Vitamin D Dosages	nan	COMPLETED

Related proteins — ESM-2 sequence neighbours (a TFDP2 binder may also engage these)

Protein	Name	Similarity
Q08639	—	1.000	Q08639 →
Q64163	—	1.000	Q64163 →
Q17QZ4	—	1.000	Q17QZ4 →
Q24318	—	1.000	Q24318 →
Q14186	—	0.999	Q14186 →
P56931	—	0.999	P56931 →
P06537	—	0.999	P06537 →
P06536	—	0.999	P06536 →
Q15329	—	0.998	Q15329 →
P49844	—	0.998	P49844 →
Q8C0I4	—	0.998	Q8C0I4 →
P70284	—	0.997	P70284 →
Q62814	—	0.997	Q62814 →
Q9FNY2	—	0.997	Q9FNY2 →
P46200	—	0.997	P46200 →
Q6NN85	—	0.997	Q6NN85 →
Q5HZN1	—	0.997	Q5HZN1 →
Q2KHR2	—	0.997	Q2KHR2 →
Q3YC04	—	0.997	Q3YC04 →
Q4VYR7	—	0.997	Q4VYR7 →
Q91904	—	0.996	Q91904 →
Q52LR7	—	0.996	Q52LR7 →
Q8VII8	—	0.996	Q8VII8 →
Q20619	—	0.996	Q20619 →
Q96AV8	—	0.996	Q96AV8 →
Q84T61	—	0.996	Q84T61 →
Q6DDJ5	—	0.996	Q6DDJ5 →
Q5R9P5	—	0.996	Q5R9P5 →
Q9FNY0	—	0.996	Q9FNY0 →
Q9JJN2	—	0.996	Q9JJN2 →